Sherif A. Abdel-Fattah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sherif A. Abdel-Fattah has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Phillipa M. Kyle
2 shared publicationsAbha Bhat
Fetal Medicine Research Unit, University of Bristol, St Michael's Hospital, Bristol, UK
1 shared publication- Abi Merriel
University of Liverpool, UK
1 shared publication Alyson Hunter
1 shared publicationDavid Carrington
Specialist Virology Centre, Health Protection Agency, South West Regional Laboratory, Bristol, UK
1 shared publicationJose L. Bartha
Fetal Medicine Research Unit, University of Bristol, St Michael's Hospital, Bristol, UK
1 shared publication
Latest Publications
- 1 January 2021
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 256, 32-39
Implications of non-invasive prenatal testing for identifying and managing high-risk pregnancies
- 1 January 2021
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 256, 32-39
Implications of non-invasive prenatal testing for identifying and managing high-risk pregnancies
- 17 October 2005
- Published by Wiley in Prenatal Diagnosis
- Vol. 25 (11) , 1028-1031
TORCH test for fetal medicine indications: only CMV is necessary in the United Kingdom
Objectives To review the indications and value of TORCH testing (toxoplasma, rubella, cytomegalovirus, herpes) for fetal medicine reasons. Methods Analysis of all maternal and fetal TORCH tests requested from a busy Fetal Medicine Unit during nearly a 10-year period. The main ultrasound findings considered as possibly caused by congenital fetal infections were analysed. Pregnancy outcomes for cases with confirmed maternal or fetal infections were studied. Results Four hundred and sixty-two maternal TORCH tests were performed. Of those, TORCH tests were also performed on fetal samples (amniotic fluid or fetal blood) in 67 cases. Fourteen fetal tests without maternal testing were identified, making the total number of patients tested 476. There were 11 cases of maternal CMV infection (2.3%), 10 cases of fetal CMV infection, and none of the other viruses. Indications for testing included fetal hyperechogenic bowel, hydrops, cerebral ventriculomegaly, echogenic foci, oligohydramnios, polyhydramnios, and IUGR. The most common findings to be actually associated with fetal infections were hyperechogenic bowel, ascites, cardiomegaly, and oligohydramnios. No cases were associated with polyhydramnious, while both IUGR and ventriculomegaly were always associated with other more relevant features. Conclusion In the United Kingdom, complete maternal TORCH testing because of fetal findings on detailed scans is often not necessary. Testing can be limited only to CMV, particularly since other infectious agents, including toxoplasmosis, are uncommon in the United Kingdom. More understanding of the relevance of the different ultrasound features to congenital infections is also important. Copyright © 2005 John Wiley & Sons, Ltd.
- 17 October 2005
- Published by Wiley in Prenatal Diagnosis
- Vol. 25 (11) , 1028-1031
TORCH test for fetal medicine indications: only CMV is necessary in the United Kingdom
Objectives To review the indications and value of TORCH testing (toxoplasma, rubella, cytomegalovirus, herpes) for fetal medicine reasons. Methods Analysis of all maternal and fetal TORCH tests requested from a busy Fetal Medicine Unit during nearly a 10-year period. The main ultrasound findings considered as possibly caused by congenital fetal infections were analysed. Pregnancy outcomes for cases with confirmed maternal or fetal infections were studied. Results Four hundred and sixty-two maternal TORCH tests were performed. Of those, TORCH tests were also performed on fetal samples (amniotic fluid or fetal blood) in 67 cases. Fourteen fetal tests without maternal testing were identified, making the total number of patients tested 476. There were 11 cases of maternal CMV infection (2.3%), 10 cases of fetal CMV infection, and none of the other viruses. Indications for testing included fetal hyperechogenic bowel, hydrops, cerebral ventriculomegaly, echogenic foci, oligohydramnios, polyhydramnios, and IUGR. The most common findings to be actually associated with fetal infections were hyperechogenic bowel, ascites, cardiomegaly, and oligohydramnios. No cases were associated with polyhydramnious, while both IUGR and ventriculomegaly were always associated with other more relevant features. Conclusion In the United Kingdom, complete maternal TORCH testing because of fetal findings on detailed scans is often not necessary. Testing can be limited only to CMV, particularly since other infectious agents, including toxoplasmosis, are uncommon in the United Kingdom. More understanding of the relevance of the different ultrasound features to congenital infections is also important. Copyright © 2005 John Wiley & Sons, Ltd.
- 19 August 2005
- Published by S. Karger AG in Fetal Diagnosis and Therapy
- Vol. 20 (5) , 341-345
Reassuring Fetal Middle Cerebral Artery Doppler Velocimetry in Alloimmunised Pregnancies: Neonatal Outcomes without Invasive Procedures
Objective: To assess the neonatal outcome in red blood cell alloimmunised pregnancies at increased risk of fetal anaemia where invasive testing was avoided based on reassuring middle cerebral artery (MCA) Doppler velocity results. Methods: We included 28 alloimmunised pregnant women at significant risk of fetal or neonatal anaemia who did not have invasive testing because of reassuring MCA Doppler velocimetry. Women requiring invasive testing or intrauterine transfusion were excluded. Outcome measures were admission to neonatal intensive care unit, cord haemoglobin and bilirubin levels and neonatal therapy. Results: Ten neonates (36%) were anaemic at birth while 18 (64%) had normal haemoglobin. Seven neonates (25%) did not require any form of neonatal therapy, 10 (36%) had phototherapy only, 7 (25%) required exchange transfusions and 4 (14%) top-up transfusions. There were no treatment-related complications. Mean cord haemoglobin was 13.9 g/dl (range 7–18.9) and mean bilirubin was 84.1 µmol/l (range 29–192). Conclusion: Avoiding invasive procedures in pregnancies at risk of fetal anaemia by relying on reassuring MCA Doppler velocimetry did not result in life-threatening fetal or neonatal morbidities. The extent of neonatal therapy was acceptable. The routine use of this test can lead to less unnecessary invasive procedures in at-risk fetuses.
- 19 August 2005
- Published by S. Karger AG in Fetal Diagnosis and Therapy
- Vol. 20 (5) , 341-345
Reassuring Fetal Middle Cerebral Artery Doppler Velocimetry in Alloimmunised Pregnancies: Neonatal Outcomes without Invasive Procedures
Objective: To assess the neonatal outcome in red blood cell alloimmunised pregnancies at increased risk of fetal anaemia where invasive testing was avoided based on reassuring middle cerebral artery (MCA) Doppler velocity results. Methods: We included 28 alloimmunised pregnant women at significant risk of fetal or neonatal anaemia who did not have invasive testing because of reassuring MCA Doppler velocimetry. Women requiring invasive testing or intrauterine transfusion were excluded. Outcome measures were admission to neonatal intensive care unit, cord haemoglobin and bilirubin levels and neonatal therapy. Results: Ten neonates (36%) were anaemic at birth while 18 (64%) had normal haemoglobin. Seven neonates (25%) did not require any form of neonatal therapy, 10 (36%) had phototherapy only, 7 (25%) required exchange transfusions and 4 (14%) top-up transfusions. There were no treatment-related complications. Mean cord haemoglobin was 13.9 g/dl (range 7–18.9) and mean bilirubin was 84.1 µmol/l (range 29–192). Conclusion: Avoiding invasive procedures in pregnancies at risk of fetal anaemia by relying on reassuring MCA Doppler velocimetry did not result in life-threatening fetal or neonatal morbidities. The extent of neonatal therapy was acceptable. The routine use of this test can lead to less unnecessary invasive procedures in at-risk fetuses.
- 9 August 2004
- Published by Wiley in Prenatal Diagnosis
- Vol. 24 (8) , 605-608
Safety of fetal blood sampling by cordocentesis in fetuses with single umbilical arteries
- 9 August 2004
- Published by Wiley in Prenatal Diagnosis
- Vol. 24 (8) , 605-608
Safety of fetal blood sampling by cordocentesis in fetuses with single umbilical arteries